loader
Please Wait
Applying Filters...
menu
    • menu

    Setid 07b71b73 1ca3 4e78 A787 E458917f1f23 Applno 208772 Form Tablet Oral Dosage 180mg - Drug Product Composition: Brigatinib

    Menu

    Brigatinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 208772 / DOSAGE - TABLET;ORAL - 180MG

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    Brigatinib(UNII: HYW8DB273J)
    (Brigatinib - UNII:HYW8DB273J)     		Brigatinib30mg

    Inactive Ingredients

    Ingredient Name
    ARIAD Pharmaceuticals Inc.
    Takeda Pharmaceuticals America, Inc.
    Lactose monohydrate(EWQ57Q8I5X)
    Magnesium stearate(70097M6I30)
    Microcrystalline cellulose(OP1R32D61U)
    POLYVINYL ALCOHOL, UNSPECIFIED(532B59J990) 
    SILICA DIMETHYL SILYLATE(EU2PSP0G0W) 
    SILICON DIOXIDE(ETJ7Z6XBU4) 
    SODIUM STARCH GLYCOLATE TYPE A POTATO(5856J3G2A2)
    WATER(059QF0KO0R) 
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.